Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Paul Scopa Insider Profile
4 Followers
James Paul Scopa, Director at Trivascular Technologies, holds 103.33K shares in Adverum Biotechnologies (Ticker: ADVM), holds 183.08K shares in Aligos Therapeutics (Ticker: ALGS), holds 0.00 shares in Dice Therapeutics (Ticker: DICE). Most recently, James Paul Scopa Bought ― shares of Adverum Biotechnologies on Feb 09, 2024 for an estimated value of 135.00K.
James Paul Scopa Trivascular Technologies (TRIV)Director
Trivascular Technologies (TRIV)
Director
Ranked #18,847 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
+14.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Paul Scopa holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 06, 2019 - May 06, 2020
Return:+204.70%
The most profitable trade made by James Paul Scopa
James Paul Scopa's Trading History
Trivascular Technologies
Feb 04, 2016
―
Uninformative Sell
―
$0.00
Adverum Biotechnologies
Feb 09, 2024
Director
Informative Buy
135.00K
$1.08M
Aligos Therapeutics
Oct 27, 2023
Director
Uninformative Buy
137.31K
$148.30K
Dice Therapeutics
Aug 09, 2023
―
Uninformative Sell
―
$0.00
Histogen
Aug 01, 2013
Director
Uninformative Buy
183.88K
$178.81K
List of latest transactions for each holding click on a transaction to see James Paul Scopa's performance on stock
You May Also Like
James Paul Scopa insider profile FAQ
What is the percentage of profitable transactions made by James Paul Scopa?
The percentage of profitable transactions made by James Paul Scopa is 33%.
What is the average return per transaction made by James Paul Scopa?
The average return per transaction made by James Paul Scopa is 14.30%.
What stocks does James Paul Scopa hold?
James Paul Scopa holds: TRIV, ADVM, ALGS, DICE, HSTO stocks.
What was James Paul Scopa’s latest transaction?
James Paul Scopa latest transaction was an Informative Buy of $135.00K.
What was James Paul Scopa's most profitable transaction?
James Paul Scopa’s most profitable transaction was an Informative Buy of ADVM stock on May 6, 2019. The return on the trade was 204.70%.
What is James Paul Scopa's role in Trivascular Technologies?
James Paul Scopa's role in Trivascular Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.